{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:13:44Z","timestamp":1775002424392,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3N0081-83"],"award-info":[{"award-number":["CMRPG3N0081-83"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.msard.2025.106703","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T22:27:46Z","timestamp":1755988066000},"page":"106703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Alteration of bile acid profile in patients with neuromyelitis optica spectrum disorders and multiple sclerosis"],"prefix":"10.1016","volume":"103","author":[{"given":"Chiung-Mei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Sun","family":"Ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Shi","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chou","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Feng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Shiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Che","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4972-9823","authenticated-orcid":false,"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106703_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17116\/jnevro201811808262","article-title":"The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT","volume":"118","author":"Abdurasulova","year":"2018","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.msard.2025.106703_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790925","article-title":"Antcin K inhibits TNF-alpha, IL-1beta and IL-8 expression in synovial fibroblasts and ameliorates cartilage degradation: implications for the treatment of rheumatoid arthritis","volume":"12","author":"Achudhan","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.msard.2025.106703_bib0003","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1172\/JCI129401","article-title":"Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation","volume":"130","author":"Bhargava","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.msard.2025.106703_bib0004","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.1700183","article-title":"The bile acid receptor GPBAR1 regulates the M1\/M2 phenotype of intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis","volume":"199","author":"Biagioli","year":"2017","journal-title":"J. Immunol."},{"issue":"52","key":"10.1016\/j.msard.2025.106703_bib0005","doi-asserted-by":"crossref","first-page":"33446","DOI":"10.1073\/pnas.2020619117","article-title":"FXR mediates T cell-intrinsic responses to reduced feeding during infection","volume":"117","author":"Campbell","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.msard.2025.106703_bib0006","first-page":"495","article-title":"The influence of interferon beta-1b on gut microbiota composition in patients with multiple sclerosis","volume":"36","author":"Castillo-Alvarez","year":"2021","journal-title":"Neurologia"},{"key":"10.1016\/j.msard.2025.106703_bib0007","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2014.11.004","article-title":"Biomarkers for neuromyelitis optica","volume":"440","author":"Chang","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.msard.2025.106703_bib0008","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/metabo14070394","article-title":"Diagnostic potential of alternations of bile acid profiles in the plasma of patients with Huntington's disease","volume":"14","author":"Chiang","year":"2024","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.msard.2025.106703_bib0010","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2025.106703_bib0011","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2018.05.002","article-title":"An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil","volume":"37","author":"Flannigan","year":"2018","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.msard.2025.106703_bib0012","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"issue":"7785","key":"10.1016\/j.msard.2025.106703_bib0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.msard.2025.106703_bib0014","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1189\/jlb.0812396","article-title":"Bile acids PKA-dependently induce a switch of the IL-10\/IL-12 ratio and reduce proinflammatory capability of human macrophages","volume":"94","author":"Haselow","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.msard.2025.106703_bib0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1189\/jlb.0812396","article-title":"Bile acids PKA-dependently induce a switch of the IL-10\/IL-12 ratio and reduce proinflammatory capability of human macrophages","volume":"94","author":"Haselow","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"Icoz","year":"2010","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"27","key":"10.1016\/j.msard.2025.106703_bib0018","doi-asserted-by":"crossref","first-page":"12486","DOI":"10.1016\/S0021-9258(18)67113-3","article-title":"Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid to chenodeoxycholic acid","volume":"261","author":"Javitt","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.msard.2025.106703_bib0019","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/glia.23663","article-title":"Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation","volume":"67","author":"Karunakaran","year":"2019","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0020","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1212\/NXI.0000000000000517","article-title":"Disease-modifying therapies alter gut microbial composition in MS","volume":"6","author":"Katz Sand","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1-2","key":"10.1016\/j.msard.2025.106703_bib0021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2011.08.043","article-title":"Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders","volume":"311","author":"Kira","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.msard.2025.106703_bib0022","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1016\/S0021-9258(19)69141-6","article-title":"Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid in the hamster","volume":"256","author":"Kok","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management","volume":"271","author":"Kumpfel","year":"2024","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106703_bib0024","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.msard.2025.106703_bib0025","article-title":"Correlation between fecal microbiota and corticosteroid responsiveness in primary immune thrombocytopenia: an exploratory study","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0026","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-an emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.msard.2025.106703_bib0027","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1194\/jlr.M400157-JLR200","article-title":"Bioconversion of 3beta-hydroxy-5-cholenoic acid into chenodeoxycholic acid by rat brain enzyme systems","volume":"45","author":"Mano","year":"2004","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.msard.2025.106703_bib0028","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3748\/wjg.15.804","article-title":"Bile acids: chemistry, physiology, and pathophysiology","volume":"15","author":"Monte","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106703_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.897867","article-title":"Distinct bile acid signature in Parkinson's disease with mild cognitive impairment","volume":"13","author":"Nie","year":"2022","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106703_bib0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.msard.2025.106703_bib0031","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.dld.2014.01.159","article-title":"Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms","volume":"46","author":"Quinn","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"4","key":"10.1016\/j.msard.2025.106703_bib0032","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acn3.51004","article-title":"Gut microbiome variation is associated to Mmltiple sclerosis phenotypic subtypes","volume":"7","author":"Reynders","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106703_bib0033","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"19","key":"10.1016\/j.msard.2025.106703_bib0034","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acs.analchem.5b01556","article-title":"Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry","volume":"87","author":"Sarafian","year":"2015","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.msard.2025.106703_bib0035","article-title":"Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial","volume":"5","author":"Storm-Larsen","year":"2019","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0036","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.msard.2025.106703_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106703_bib0038","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/1352458516672015","article-title":"Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood-brain barrier disruption","volume":"23","author":"Uchida","year":"2017","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2025.106703_bib0039","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106703_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"Uzawa","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.msard.2025.106703_bib0041","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2025.106703_bib0042","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/cns.14154","article-title":"Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain","volume":"29","author":"Wu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.msard.2025.106703_bib0043","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.dld.2016.03.022","article-title":"Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts","volume":"48","author":"Xiao","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"4","key":"10.1016\/j.msard.2025.106703_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.msard.2025.106703_bib0045","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARalpha nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:17:43Z","timestamp":1774999063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"alternative-id":["S2211034825004456"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106703","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alteration of bile acid profile in patients with neuromyelitis optica spectrum disorders and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106703"}}